Technical Analysis for NXL - Nexalin Technology, Inc.

Grade Last Price % Change Price Change
F 1.06 -5.22% -0.06
NXL closed down 5.22 percent on Monday, January 30, 2023, on 32 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Weak + Overbought Other 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Doji - Bearish? Reversal -5.22%
Stochastic Reached Overbought Strength -5.22%
Weak + Overbought Other -5.22%
Outside Day Range Expansion -5.22%
Wide Bands Range Expansion -5.22%
Weak, Overbought and Reversal Signs Reversal -5.22%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Support 6 days ago
Rose Above Previous Day's High 6 days ago
Down 5% 6 days ago
Down 3% 6 days ago
Up 3% 6 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Neuroscience Alzheimer's Disease Mental Health Chronic Pain Psychiatric Diagnosis Dementia Psychiatry Insomnia Mental Disorder Neurostimulation Mental Health Disorders

Is NXL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.23
52 Week Low 0.6505
Average Volume 213,276
200-Day Moving Average 0.00
50-Day Moving Average 1.38
20-Day Moving Average 0.94
10-Day Moving Average 1.04
Average True Range 0.15
RSI 49.24
ADX 20.14
+DI 16.40
-DI 15.94
Chandelier Exit (Long, 3 ATRs) 0.71
Chandelier Exit (Short, 3 ATRs) 1.09
Upper Bollinger Bands 1.19
Lower Bollinger Band 0.69
Percent B (%b) 0.74
BandWidth 53.62
MACD Line -0.04
MACD Signal Line -0.09
MACD Histogram 0.0495
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.20
Resistance 3 (R3) 1.20 1.16 1.17
Resistance 2 (R2) 1.16 1.13 1.16 1.16
Resistance 1 (R1) 1.11 1.10 1.09 1.11 1.16
Pivot Point 1.07 1.07 1.06 1.07 1.07
Support 1 (S1) 1.02 1.04 1.00 1.02 0.96
Support 2 (S2) 0.98 1.01 0.98 0.96
Support 3 (S3) 0.93 0.98 0.95
Support 4 (S4) 0.93